Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo.

Mol Cancer Ther · 2022 · PMC9377726 · PMID 35027480

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Ad1 and Ad6 also showed a trend towards improved oncolysis in most cell lines, including PANC-I, A549, U-2 OS, and Caco-2 cells (both lung cancer), although not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.